Publicaciones en las que colabora con RAFAEL GONZÁLEZ CANO (20)

2023

  1. Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity

    Journal of Medicinal Chemistry, Vol. 66, Núm. 16, pp. 11447-11463

  2. Minocycline Prevents the Development of Key Features of Inflammation and Pain in DSS-induced Colitis in Mice

    Journal of Pain, Vol. 24, Núm. 2, pp. 304-319

  3. Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands

    ACS Chemical Neuroscience, Vol. 14, Núm. 10, pp. 1845-1858

2022

  1. Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation

    European Journal of Medicinal Chemistry, Vol. 230

  2. Soluble Epoxide Hydrolase Inhibitors: Design, Synthesis, in vitro Profiling and in vivo Evaluation in Murine Models of Pain

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 36

  3. Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors

    Journal of medicinal chemistry, Vol. 65, Núm. 20, pp. 13660-13680

2021

  1. Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain

    Pharmacological Research, Vol. 163

2020

  1. El receptor sigma-1: una diana farmacológica que modula las interacciones neuroinmunitarias y neurogliales durante el dolor crónico

    Actualidad en farmacología y terapéutica, Vol. 18, Núm. 3, pp. 173-186

  2. Intracolonic Mustard Oil Induces Visceral Pain in Mice by TRPA1-Dependent and -Independent Mechanisms: Role of Tissue Injury and P2X Receptors

    Frontiers in Pharmacology, Vol. 11

  3. The search for translational pain outcomes to refine analgesic development: Where did we come from and where are we going?

    Neuroscience and Biobehavioral Reviews, Vol. 113, pp. 238-261

2018

  1. Mechanistic Differences in Neuropathic Pain Modalities Revealed by Correlating Behavior with Global Expression Profiling

    Cell Reports, Vol. 22, Núm. 5, pp. 1301-1312

  2. Modality-specific peripheral antinociceptive effects of μ-opioid agonists on heat and mechanical stimuli: Contribution of sigma-1 receptors

    Neuropharmacology, Vol. 135, pp. 328-342

  3. Targeting immune-driven opioid analgesia by sigma-1 receptors: Opening the door to novel perspectives for the analgesic use of sigma-1 antagonists

    Pharmacological Research, Vol. 131, pp. 224-230

2017

  1. Mild Social Stress in Mice Produces Opioid-Mediated Analgesia in Visceral but Not Somatic Pain States

    Journal of Pain, Vol. 18, Núm. 6, pp. 716-725

  2. Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 31, pp. 8396-8401

2016

  1. Sigma-1 Receptor Agonism Promotes Mechanical Allodynia After Priming the Nociceptive System with Capsaicin

    Scientific Reports, Vol. 6

2014

  1. Modulation of peripheral μ-opioid analgesia by σ1 receptors

    Journal of Pharmacology and Experimental Therapeutics, Vol. 348, Núm. 1, pp. 32-45

2013

  1. El receptor Sigma (s 1): Un freno biológico a la analgesia opioide periférica

    Actualidad en farmacología y terapéutica, Vol. 11, Núm. 4, pp. 282-284

  2. Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptors

    Neuropharmacology, Vol. 70, pp. 348-358

2012

  1. Tetrodotoxin (TTX) as a therapeutic agent for pain

    Marine Drugs, Vol. 10, Núm. 2, pp. 281-305